Mologic Ltd - Product Pipeline Analysis, 2026 Update
Description
Summary
Mologic Ltd (GADx), a subsidiary of Global Access Health, is a developer of lateral flow and rapid diagnostic technologies that focuses on delivering fast, reliable point-of-care tests. The company provides contract research and development for lateral flow immunoassays, including reagents and antibodies, nanobody development, assay design, device housing design and prototyping, evaluation, validation, and support. Its product includes IT LEISH, which is a test for antibody detection in human visceral leishmaniasis. GADx also offers bioconjugation and diagnostic chemistry services and provides clinical trial services for medical devices, from protocol design through trial management and compliance support. Its products and services serve human, veterinary and agricultural applications. GADx is headquartered in Bedford, Bedfordshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
Mologic Ltd (GADx), a subsidiary of Global Access Health, is a developer of lateral flow and rapid diagnostic technologies that focuses on delivering fast, reliable point-of-care tests. The company provides contract research and development for lateral flow immunoassays, including reagents and antibodies, nanobody development, assay design, device housing design and prototyping, evaluation, validation, and support. Its product includes IT LEISH, which is a test for antibody detection in human visceral leishmaniasis. GADx also offers bioconjugation and diagnostic chemistry services and provides clinical trial services for medical devices, from protocol design through trial management and compliance support. Its products and services serve human, veterinary and agricultural applications. GADx is headquartered in Bedford, Bedfordshire, the UK.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Mologic Ltd
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
59 Pages
- Mologic Ltd Company Overview
- Mologic Ltd Company Snapshot
- Mologic Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Mologic Ltd – Pipeline Analysis Overview
- Mologic Ltd - Key Facts
- Mologic Ltd - Major Products and Services
- Mologic Ltd Pipeline Products by Development Stage
- Mologic Ltd Ongoing Clinical Trials by Trial Status
- Mologic Ltd Pipeline Products Overview
- ACuTEGA
- ACuTEGA Product Overview
- BVPro - Home Use
- BVPro - Home Use Product Overview
- BVThrush Combi
- BVThrush Combi Product Overview
- Dengue Fever Diagnostic Test - Professional Use
- Dengue Fever Diagnostic Test - Professional Use Product Overview
- Dentiplex
- Dentiplex Product Overview
- DENTiPLEX BL
- DENTiPLEX BL Product Overview
- Diagnostic Test - Ebola Virus
- Diagnostic Test - Ebola Virus Product Overview
- Diagnostic Test - Malaria
- Diagnostic Test - Malaria Product Overview
- Diagnostic Test - Measles
- Diagnostic Test - Measles Product Overview
- Diagnostic Test - Rubella
- Diagnostic Test - Rubella Product Overview
- Diagnostic Test - TB LAM
- Diagnostic Test - TB LAM Product Overview
- Diagnostic Test - TB LAM Clinical Trial
- Diagnostic Test - Yellow Fever
- Diagnostic Test - Yellow Fever Product Overview
- HeadStart
- HeadStart Product Overview
- HeadsUp
- HeadsUp Product Overview
- Next Generation COVID-19 Antigen Test
- Next Generation COVID-19 Antigen Test Product Overview
- Point Of Care Test - Urinary Tract Infections
- Point Of Care Test - Urinary Tract Infections Product Overview
- Point-of Care Test - Sepsis
- Point-of Care Test - Sepsis Product Overview
- Point-of Care Test - Sepsis Clinical Trial
- Point-Of-Care Test - COVID-19
- Point-Of-Care Test - COVID-19 Product Overview
- Rapid Diagnostic Test - HCV
- Rapid Diagnostic Test - HCV Product Overview
- Rapid Diagnostic Test - Onchocerciasis
- Rapid Diagnostic Test - Onchocerciasis Product Overview
- Rapid Diagnostic Test - Schistosomiasis
- Rapid Diagnostic Test - Schistosomiasis Product Overview
- RightStart
- RightStart Product Overview
- Second Generation Pan Fever Diagnostic Test
- Second Generation Pan Fever Diagnostic Test Product Overview
- Utriplex
- Utriplex Product Overview
- Mologic Ltd - Key Competitors
- Mologic Ltd - Key Employees
- Mologic Ltd - Locations And Subsidiaries
- Head Office
- Recent Developments
- Mologic Ltd, Recent Developments
- Nov 06, 2025: GADx And BBI Solutions Collaborate On Lateral Flow Development
- Oct 16, 2025: Reflections On Diagnostics At IPSC 2025
- May 23, 2025: Official Launch of the UTI-Diag Project Innovating for Better Diagnosis of Urinary Tract Infections
- May 19, 2025: Developing a Bivalent Vaccine for Nipah virus and a companion DIVA rapid lateral flow test
- Jan 10, 2025: Advancing Regional Diagnostics: GADx at DIATROPIX Launch
- Aug 15, 2024: New Study Investigates Biomarkers for Kidney Health Assessment
- Jun 24, 2024: GADx Contributes to TB Diagnostic Advancements
- Feb 24, 2023: US FDA grants EUA to the Mologic COVI-Go SARS-CoV-2 Ag Self-Test
- Sep 30, 2022: GADx Reintroduces IT LEISH, The Rapid Diagnostic Test for Visceral Leishmaniasis
- Dec 13, 2021: Latest study verifies detection of Covios Ag lateral flow test to Omicron variant
- Appendix
- Methodology
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Mologic Ltd Pipeline Products and Ongoing Clinical Trials Overview
- Mologic Ltd Pipeline Products by Equipment Type
- Mologic Ltd Pipeline Products by Indication
- Mologic Ltd Ongoing Clinical Trials by Trial Status
- Mologic Ltd, Key Facts
- Mologic Ltd, Major Products and Services
- Mologic Ltd Number of Pipeline Products by Development Stage
- Mologic Ltd Pipeline Products Summary by Development Stage
- Mologic Ltd Ongoing Clinical Trials by Trial Status
- Mologic Ltd Ongoing Clinical Trials Summary
- ACuTEGA - Product Status
- ACuTEGA - Product Description
- BVPro - Home Use - Product Status
- BVPro - Home Use - Product Description
- BVThrush Combi - Product Status
- BVThrush Combi - Product Description
- Dengue Fever Diagnostic Test - Professional Use - Product Status
- Dengue Fever Diagnostic Test - Professional Use - Product Description
- Dentiplex - Product Status
- Dentiplex - Product Description
- DENTiPLEX BL - Product Status
- DENTiPLEX BL - Product Description
- Diagnostic Test - Ebola Virus - Product Status
- Diagnostic Test - Ebola Virus - Product Description
- Diagnostic Test - Malaria - Product Status
- Diagnostic Test - Malaria - Product Description
- Diagnostic Test - Measles - Product Status
- Diagnostic Test - Measles - Product Description
- Diagnostic Test - Rubella - Product Status
- Diagnostic Test - Rubella - Product Description
- Diagnostic Test - TB LAM - Product Status
- Diagnostic Test - TB LAM - Product Description
- Diagnostic Test - TB LAM - Rapid Research in Diagnostics Development for TB Network (R2D2 TB Network) Study
- Diagnostic Test - Yellow Fever - Product Status
- Diagnostic Test - Yellow Fever - Product Description
- HeadStart - Product Status
- HeadStart - Product Description
- HeadsUp - Product Status
- HeadsUp - Product Description
- Next Generation COVID-19 Antigen Test - Product Status
- Next Generation COVID-19 Antigen Test - Product Description
- Point Of Care Test - Urinary Tract Infections - Product Status
- Point Of Care Test - Urinary Tract Infections - Product Description
- Point-of Care Test - Sepsis - Product Status
- Point-of Care Test - Sepsis - Product Description
- Point-of Care Test - Sepsis - An Observational Study of Host Biomarker Signatures That Predict the Onset of Sepsis in Patients With Lower Respiratory Tract Infections Including COVID-19: Utility in Managing Patients at Risk of Multi Organ Failure.
- Point-Of-Care Test - COVID-19 - Product Status
- Point-Of-Care Test - COVID-19 - Product Description
- Rapid Diagnostic Test - HCV - Product Status
- Rapid Diagnostic Test - HCV - Product Description
- Rapid Diagnostic Test - Onchocerciasis - Product Status
- Rapid Diagnostic Test - Onchocerciasis - Product Description
- Rapid Diagnostic Test - Schistosomiasis - Product Status
- Rapid Diagnostic Test - Schistosomiasis - Product Description
- RightStart - Product Status
- RightStart - Product Description
- Second Generation Pan Fever Diagnostic Test - Product Status
- Second Generation Pan Fever Diagnostic Test - Product Description
- Utriplex - Product Status
- Utriplex - Product Description
- Mologic Ltd, Key Employees
- Glossary
- List of Figures
- Mologic Ltd Pipeline Products by Equipment Type
- Mologic Ltd Pipeline Products by Development Stage
- Mologic Ltd Ongoing Clinical Trials by Trial Status
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
